Zevra Therapeutics (ZVRA) Cash & Equivalents Growth (1y) (2015 - 2026)
Zevra Therapeutics (ZVRA) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Zevra Therapeutics |
787.90 Mn |
587.28 Mn |
34.30 Mn |
156.01% |
| Date | Value |
|---|
| Mar 31, 2026 |
156.01% |
| Dec 31, 2025 |
84.72% |
| Sep 30, 2025 |
0.74% |
| Jun 30, 2025 |
21.53% |
| Mar 31, 2025 |
-12.86% |
| Dec 31, 2024 |
-21.52% |
| Jun 30, 2024 |
-40.69% |
| Mar 31, 2024 |
6.64% |
| Dec 31, 2023 |
-34.24% |
| Jun 30, 2023 |
-13.78% |
| Dec 31, 2022 |
-41.73% |
| Sep 30, 2022 |
-46.72% |
| Jun 30, 2022 |
-41.96% |
| Dec 31, 2021 |
2,566.65% |
| Sep 30, 2021 |
2,396.73% |
| Jun 30, 2021 |
1,977.17% |
| Mar 31, 2021 |
3,122.28% |
| Dec 31, 2020 |
30.96% |
| Sep 30, 2020 |
-19.19% |
| Jun 30, 2020 |
-12.85% |
